Genetic assessment and management in high-risk patients.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Pascal PUJOL
Genetician, Montpellier, France

What strategy to use to manage side effects in practice?
Georgia DEMETRIOU
oncologist, Johannesburg, SA
Breast surgery indication in MBC.
Rita SAKR
Surgeon, Dubai, UAE
Surgery options in Thoracic MBC.
Karima ACHOUR
Surgeon, Bab El Oued , Algeria
Imaging follow up after breast recontruction
THU HA DAO
Innovations in breast metastatic cancer
Frédérique PENAULT LLORCA Pathologist, Clermont Ferrand, France